Viewing Study NCT02705612


Ignite Creation Date: 2025-12-26 @ 10:19 PM
Ignite Modification Date: 2025-12-26 @ 10:19 PM
Study NCT ID: NCT02705612
Status: UNKNOWN
Last Update Posted: 2016-03-10
First Post: 2016-03-05
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Phase II Clinical Trial of Concurrent Chemoradiotherapy Combined Nimotuzumab for Stage IIB-IVA Cervical Cancer
Sponsor: Air Force Military Medical University, China
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module